Kite Pharma
Biotechnology company developing and commercializing cell therapies for cancer treatment.
About
Technology stack
detected 2026-06-19No comments yet. Be the first to share your take.
What does Kite Pharma do?
Kite Pharma is a biotechnology company focused on developing and commercializing innovative cancer immunotherapy products, primarily through genetically engineered autologous CAR T cell therapy. Founded in 2009, it was acquired by Gilead Sciences in 2017 and operates as a subsidiary dedicated to advancing personalized treatments in immuno-oncology.
How much funding has Kite Pharma raised?
Kite Pharma has raised a total of $421M in funding. The most recent round on record is Venture.
Where is Kite Pharma headquartered?
Kite Pharma is headquartered in Santa Monica, United States.
When was Kite Pharma founded?
Kite Pharma was founded in 2009.
What industry does Kite Pharma operate in?
Kite Pharma operates in Biotechnology, Pharmaceuticals, Oncology, Cell Therapy.